Department


Pharmacy Practice

Professor
Focus: Endocrinology

Contact Information
(518) 694-7239
michael.kane@acphs.edu


Speaker Request
Michael P. Kane, PHARM.D., FCCP, BCPS, BCACP

EDUCATION

  • Pharm.D., Medical University of South Carolina 
  • Clinical Pharmacy Resident, Adult Internal Medicine, Medical University Hospital Medical University of South Carolina, Charleston, SC
  • Hospital Pharmacy Resident, Greenwich Hospital Association Greenwich, CT 
  • B.S., Albany College of Pharmacy and Health Sciences

COURSES TAUGHT AT ACPHS

  • Integrated Problem Solving Workshop 6 (Facilitator)
  • PTPM Endocrinology
  • APPE - Ambulatory Care Endocrinology/Internal Medicine rotation

RESEARCH INTERESTS

  • Assessing the safety and efficacy of new drugs in the management of diabetes mellitus and osteoporosis.

HONORS AND APPOINTMENTS

  • Recipient of the 2010 American College of Clinical Pharmacy, Clinical Practice Award; presented October 14, 2010, Austin, TX
  • Appointed to Board of Trustees of Northeast Kidney Foundation in 2015
  • 2018 - My biography has been accepted into Marquis Who's Who in the World (comprised of the top 3% of the professionals in the world)
  • Elected to the Capital District Men’s Senior Baseball League Hall of Fame, March 2020.

CLINICAL AFFILIATIONS

  • Clinical Pharmacy Specialist – Albany Medical Center Division of Community Endocrinology (formerly The Endocrine Group), Albany, NY
  • Preceptor – Residency in Adult Internal Medicine/Endocrinology
  • Fellow of the American College of Clinical Pharmacy
  • Board Certified in Pharmacotherapy (since 1991)
  • Board Certified in Ambulatory Care Pharmacy (since 2011)

SCHOLARLY ACTIVITY

PUBLICATIONS
  • Kane MP, Triplitt C, Solis-Herrera C. Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists. Accepted for publication, American Journal of Health-System Pharmacy.
  • Kuchis MM, Eldeiry A, Busch RS, Racz MJ, Kane MP. Real-World Long-Term Safety and Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors. Endocr Pract (Abstract). 2020;26(suppl 2):166-167.​​​​​​​
  • Kane MP. Updates in Therapeutics ACCP/ASHP Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2020 ed. Lenexa, KS: American College of Clinical Pharmacy, 2020:47-108. ​​​​​​​
  • Kuchis M, Kane MP. iForumRX PodCast and Script - Subclinical Hypothyroidism: Don’t Let the Numbers Fool You: Levothyroxine Isn’t a Cure-all. March 3, 2020 https://iforumrx.org/commentary/don%E2%80%99t-let-numbers-fool-you-levo…
  • McGreevy JL, Kane MP, Busch RS, Bakst G, ElDeiry SS. A pharmacist-run anabolic osteoporosis clinic: An abaloparatide descriptive report. J Am Pharm Assoc. 2019;59(4):593-597. 
  • Kane MP, Bakst G. Thyroid disorders. In: DiPiro JT, Yee GC, Posey LM, Haines ST, Nolin TD, Ellingrod V, eds. Pharmacotherapy: A Pathophysiologic Approach, 11ed. New York, NY: McGraw-Hill Education, 2019.
  • Farina K, Kane MP. Programmed Cell Death-1 Monoclonal Antibody Therapy and Type 1 Diabetes Mellitus: A Review of the Literature. J Pharm Pract. 2019 Jul 3:897190019850929. doi: 10.1177/0897190019850929 
  • Kane MP. Endocrine Disorders. In: Bainbridge JL, Cardone K, Cross LB, et al. Updates in Therapeutics ACCP/ASHP Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2019 ed. Lenexa, KS: American College of Clinical Pharmacy, 2019:631-93.
  • Kane MP. Endocrine Disorders. In: Bainbridge JL, Cardone K, Cross LB, et al. Updates in Therapeutics®: Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2018 ed. Lenexa, KS: American College of Clinical Pharmacy, 2018:1-307 - 1-368.
  • Kane MP. Endocrine Disorders. In: Bainbridge JL, Cardone K, Cross LB, et al. Updates in Therapeutics®: Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2017 ed. Lenexa, KS: American College of Clinical Pharmacy, 2017:1-262 - 1-322.
  • Jonklaas J, Kane MP. Thyroid disorders. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach, 10th edition. New York, NY: McGraw-Hill Education, 2016:1183-1206.
  • Kane MP. Endocrine Disorders. In: Bainbridge JL, Cardone K, Cross LB, et al. Updates in Therapeutics®: Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2016 ed. Lenexa, KS: American College of Clinical Pharmacy, 2016:1-679 - 1-740.

 

SELECTED POSTER/PLATFORM PRESENTATIONS
  • Kuchis MM, Eldeiry A, Busch RS, Racz M, Kane MP. Real-world long-term safety and efficacy of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. EMBRAACE 2020: The AACE 29th Annual Scientific & Clinical Congress; Washington, DC May 10, 2020. (On-line presentation due to COVID-19 pandemic).
  • Kane MP. ACCP/ASHP 2020 Ambulatory Care Pharmacy Preparatory Review and Recertification Course; Endocrine Disorders. Presented March 5, 2020, Henderson, NV.
  • Kane MP. Current Issues in Hypothyroidism. The Nurse Practitioner Association New York State 35th Annual Conference. Presented October 19, 2019, Verona, NY.
  • Kane MP. ACCP/ASHP 2019 Ambulatory Care Pharmacy Preparatory Review and Recertification Course; Endocrine Disorders. Presented May 3, 2019, Minneapolis, MN.
  • McGreevy JL, Cherian S, Kane MP, Busch RS, Racz M. A real-world GLP-1 receptor agonist switch study. Presented at the ACCP/ASHP Updates in Therapeutics 2019 meeting, St. Louis College of Pharmacy, St. Louis, Missouri, April 28, 2019.
  • Kane MP. Diabetes: It’s a word, not a sentence. Presented to the Central New York Society of Health-system Pharmacists; October 18, 2018, Syracuse, NY.
  • Kane MP. ACCP 2018 Updates In Therapeutics: The Ambulatory Care Pharmacy Preparatory Review Course; Endocrine Disorders. Presented Endocrine Disorders section of the Ambulatory Care Pharmacy Preparatory Review Course which is offered in preparation of the pharmacy Specialty Certification Examination for Board Certification in Ambulatory Care. Presented February 18, 2018, Jacksonville, FL.
RESEARCH GRANTS

The Prevalence and Burden of Hypophosphatasia in an Ambulatory Care Endocrinology Practice. Kane MP, Quinn H, Busch RS. Awarded $42,640; Alexion Pharmaceuticals; 7/20.

Simultaneous Determination of Free, Total, and Normalized Concentrations of Bioactive Compounds. Musteata FM, Kane MP. National Institutes of Health. Grant Number: 1R15GM126510-01  FAIN: R15GM126510. Awarded $480,000. 09/01/2018 – 08/31/2021.